Skip to main content
Erschienen in: Obesity Surgery 4/2009

01.04.2009 | Research Article

Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients

verfasst von: Sheng-Bin Chen, Yi-Chih Lee, Kong-Han Ser, Jung-Chien Chen, Shu Chung Chen, Hsing-Fang Hsieh, Wei-Jei Lee

Erschienen in: Obesity Surgery | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity has been widely recognized as a chronic inflammatory condition and associated with elevated inflammatory indicators including C-reactive protein (CRP) and white blood cell count (WBC). Recent studies have shown elevated CRP or WBC is a significant risk factor for cardiac events and stroke but the clinical significance of CRP and WBC has not been clearly studied in morbidly obese patients. This study is aimed at the clinical significance of WBC and CRP in morbidly obese patients and the change after bariatric surgery.

Methods

The study was a prospectively controlled clinical study. From December 1, 2001 to January 31, 2006, of 640 (442 females and 198 males) consecutive morbid obese patients enrolled in a surgically supervised weight loss program with at least 1 year’s follow-up were examined.

Results

Of the patients, 476 (74.4%) had elevated CRP and 100 (15.6%) had elevated WBC at preoperative study. CRP and WBC were significantly related and both increased with increasing body mass index (BMI). CRP is also increased with increasing waist, glucose level, hemoglobin, albumin, Ca, insulin, C-peptide, and metabolic syndrome while WBC is increased with metabolic syndrome but decreased with increasing age. Multivariate analysis confirmed fasting glucose level and hemoglobin are independent predictors of the elevation of CRP while age is the only independent predictor for elevated WBC. Both WBC and CRP levels decreased rapidly after obesity surgery. These improvements resulted in a 69.8% reduction of CRP and 26.4% reduction of WBC 1 year after surgery. Although individuals who underwent laparoscopic gastric bypass lost significantly more weight (36.8 ± 11.7 kg vs. 17.3 ± 10.8 kg; p = 0.000) and achieved a lower BMI (27.8 ± 4.6 vs. 35.0 ± 5.5; p = 0.000) than individuals who underwent laparoscopic gastric banding, there was no difference in the resolution of elevated CRP 1 year after surgery (95.9% vs. 84.5%; p = 0.169) and WBC (99.4% vs. 98.3%; p = 0.323).

Conclusions

Both baseline WBC and CRP are elevated in morbid obese patients but CRP has a better clinical significance. Significant weight reduction 1 year after surgery markedly reduced CRP and WBC with a resolution rate of 93.9% and 98.2% separately. Obesity surgery performed by laparoscopic surgery is recommended for obese patients with elevated CRP or WBC.
Literatur
1.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.CrossRef Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.CrossRef
2.
Zurück zum Zitat Dietel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people (Editorial). Obes Surg. 2003;13:329–30.CrossRef Dietel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people (Editorial). Obes Surg. 2003;13:329–30.CrossRef
3.
Zurück zum Zitat Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–5.CrossRef Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–5.CrossRef
4.
Zurück zum Zitat Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.CrossRef Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.CrossRef
5.
Zurück zum Zitat Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA. 1975;234:500–6.CrossRef Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA. 1975;234:500–6.CrossRef
6.
Zurück zum Zitat Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRef Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRef
7.
Zurück zum Zitat Lemieux I, Pascot A, Prud’homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. J Am Heart Assoc. 2001;21:961–7. Lemieux I, Pascot A, Prud’homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. J Am Heart Assoc. 2001;21:961–7.
8.
Zurück zum Zitat Yarnell JW, Baker IA, Sweetnam PM, et al. Fibronogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caephilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–44.CrossRef Yarnell JW, Baker IA, Sweetnam PM, et al. Fibronogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caephilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–44.CrossRef
9.
Zurück zum Zitat Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol. 1990;19:881–8.CrossRef Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol. 1990;19:881–8.CrossRef
10.
Zurück zum Zitat Mendall MA, Strchan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584–90.CrossRef Mendall MA, Strchan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584–90.CrossRef
11.
Zurück zum Zitat Tchernof A, Nolan, Sites C, et al. Weight loss reduces C-reactive protein levels in obese post-menopausal women. Circulation. 2002;105:564–9.CrossRef Tchernof A, Nolan, Sites C, et al. Weight loss reduces C-reactive protein levels in obese post-menopausal women. Circulation. 2002;105:564–9.CrossRef
12.
Zurück zum Zitat Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vas Biol. 2001;21:968–70.CrossRef Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vas Biol. 2001;21:968–70.CrossRef
13.
Zurück zum Zitat Okita K, Nishijima H, Murakami T, et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol. 2004;24:1868–73.CrossRef Okita K, Nishijima H, Murakami T, et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol. 2004;24:1868–73.CrossRef
14.
Zurück zum Zitat Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of its association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659–62.CrossRef Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of its association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659–62.CrossRef
15.
Zurück zum Zitat Zagorski SM, Papa NN, Chung MH. The effect of weight loss after gastric bypass on C-reactive protein levels. Surg Obes Relat Dis. 2005;1:81–5.CrossRef Zagorski SM, Papa NN, Chung MH. The effect of weight loss after gastric bypass on C-reactive protein levels. Surg Obes Relat Dis. 2005;1:81–5.CrossRef
16.
Zurück zum Zitat Dixon JB, O’Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16:251–7.CrossRef Dixon JB, O’Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16:251–7.CrossRef
17.
Zurück zum Zitat Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.CrossRef Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.CrossRef
18.
Zurück zum Zitat Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–6.CrossRef Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–6.CrossRef
19.
Zurück zum Zitat Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRef Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRef
20.
Zurück zum Zitat Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.CrossRef Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.CrossRef
21.
Zurück zum Zitat Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med. 2002;52:213–8.CrossRef Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med. 2002;52:213–8.CrossRef
22.
Zurück zum Zitat Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation. 2002;105:2462–4.CrossRef Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation. 2002;105:2462–4.CrossRef
23.
Zurück zum Zitat Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.CrossRef Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.CrossRef
24.
Zurück zum Zitat Gabay C, Krshner I. Acute-phase proteins and other systemic responses to inflammation. NEJM. 1999;340:448–54.CrossRef Gabay C, Krshner I. Acute-phase proteins and other systemic responses to inflammation. NEJM. 1999;340:448–54.CrossRef
25.
Zurück zum Zitat Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–7.CrossRef Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–7.CrossRef
26.
Zurück zum Zitat Ridker PM, Cannon CP, Marrow D, et al. C-reactive protein levels and outcomes after stain therapy. N Engl J Med. 2005;352:20–8.CrossRef Ridker PM, Cannon CP, Marrow D, et al. C-reactive protein levels and outcomes after stain therapy. N Engl J Med. 2005;352:20–8.CrossRef
27.
Zurück zum Zitat Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef
28.
Zurück zum Zitat O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.CrossRef O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.CrossRef
29.
Zurück zum Zitat Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed
30.
Zurück zum Zitat Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.CrossRef Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.CrossRef
31.
Zurück zum Zitat Deurenberg P, Deurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes. 1998;22:1164–71.CrossRef Deurenberg P, Deurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes. 1998;22:1164–71.CrossRef
32.
Zurück zum Zitat Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27:1294–6.CrossRef Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27:1294–6.CrossRef
33.
Zurück zum Zitat Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.
Metadaten
Titel
Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients
verfasst von
Sheng-Bin Chen
Yi-Chih Lee
Kong-Han Ser
Jung-Chien Chen
Shu Chung Chen
Hsing-Fang Hsieh
Wei-Jei Lee
Publikationsdatum
01.04.2009
Verlag
Springer New York
Erschienen in
Obesity Surgery / Ausgabe 4/2009
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9619-3

Weitere Artikel der Ausgabe 4/2009

Obesity Surgery 4/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.